http://www.unboundmedicine.com/medline/ebm/research/Samarium-153_lexidronamUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/18594006/full_citation/The_use_of_chelated_radionuclide__samarium_153_ethylenediaminetetramethylenephosphonate__to_modulate_phenotype_of_tumor_cells_and_enhance_T_cell_mediated_killing_Chakraborty M, Wansley EK, Carrasquillo JA, et al. 
The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing. [Journal Article]
Clin Cancer Res 2008 Jul 1; 14(13):4241-9.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18501082/full_citation/Safety_analysis_of_repeated_high_doses_of_samarium_153_lexidronam_in_men_with_hormone_naive_prostate_cancer_metastatic_to_bone_Higano CS, Quick DP, Bushnell D, et al. 
Safety analysis of repeated high doses of samarium-153 lexidronam in men with hormone-naive prostate cancer metastatic to bone. [Journal Article]
Clin Genitourin Cancer 2008 Mar; 6(1):40-5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18467311/full_citation/Myelotoxicity_of_samarium_Sm_153_lexidronam_in_patients_receiving_prior_treatment_with_chemotherapy_or_radiotherapy_Heron DE, Brufsky A, Beriwal S, et al. 
Myelotoxicity of samarium Sm 153 lexidronam in patients receiving prior treatment with chemotherapy or radiotherapy. [JOURNAL ARTICLE]
Ann Oncol 2008 May 7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18360794/full_citation/Controlled_size_and_morphology_of_EDTMP_doped_hydroxyapatite_nanoparticles_as_model_for__153_Samarium_EDTMP_doping_Han YJ, Loo SC, Phung NT, et al. 
Controlled size and morphology of EDTMP-doped hydroxyapatite nanoparticles as model for (153)Samarium-EDTMP doping. [JOURNAL ARTICLE]
J Mater Sci Mater Med 2008 Mar 25.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18157530/full_citation/Combined_use_of_zoledronic_acid_and_153Sm_EDTMP_in_hormone_refractory_prostate_cancer_patients_with_bone_metastases_Lam MG, Dahmane A, Stevens WH, et al. 
Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases. [JOURNAL ARTICLE]
Eur J Nucl Med Mol Imaging 2007 Dec 22.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18064991/full_citation/[Treatment_of_painful_bony_metastases_with_Samarium_153_EDTMP_in_prostate_carcinoma]Mhiri A, Hassad R, Sellem A, et al. 
[Treatment of painful bony metastases with Samarium 153-EDTMP in prostate carcinoma] [English Abstract, Journal Article]
Tunis Med 2007 Jul; 85(7):580-5.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18021689/full_citation/[Determination_of_dose_calibrator_setting_of_the_capintec_CRC_R__35R_for_samarium_153_]Plancha Mansanet MC, Félix Fontestad J, Caballero Calabuig EV, et al. 
[Determination of dose calibrator setting of the capintec CRC(R)-35R for samarium-153.] [JOURNAL ARTICLE]
Rev Esp Med Nucl 2007 Nov; 26(6):354-358.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18020921/full_citation/Samarium_lexidronam___153_Sm_EDTMP_:_skeletal_radiation_for_osteoblastic_bone_metastases_and_osteosarcoma_Anderson P, Nuñez R 
Samarium lexidronam ((153)Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma. [JOURNAL ARTICLE]
Expert Rev Anticancer Ther 2007 Nov; 7(11):1517-1527.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17803446/full_citation/Analysis_of_Multiple_Factors_Related_to_Hematologic_Toxicity_Following__153_Sm_EDTMP_Therapy_Liu H, Zhan H, Sun D, et al. 
Analysis of Multiple Factors Related to Hematologic Toxicity Following (153)Sm-EDTMP Therapy. [Journal Article]
Cancer Biother Radiopharm 2007 Aug; 22(4):515-20.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/17630915/full_citation/Bone_seeking_radiopharmaceuticals_for_palliation_of_pain_in_cancer_patients_with_osseous_metastases_Lam MG, de Klerk JM, van Rijk PP, et al. 
Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases. [Journal Article]
Anticancer Agents Med Chem 2007 Jul; 7(4):381-97.
Abstract | Full Citation